NCT01734954

Brief Summary

The purpose of this study is to evaluate the latency period (timing between the injection of the local anesthetic and the onset of complete sensory nerve block) of two approaches for ultrasound-guided popliteal sciatic nerve block: One of the approaches is the injection of the anesthetic just at the site of the bifurcation of the sciatic nerve and the other one is injecting the local anesthetic at least 2 cm beyond the bifurcation of the aforementioned nerve. Our main hypothesis is that the first approach will decrease the latency period, and probably, will increase the success rate of the nerve block as well as patient satisfaction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 10, 2012

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 28, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

April 19, 2013

Status Verified

April 1, 2013

Enrollment Period

4 months

First QC Date

November 10, 2012

Last Update Submit

April 17, 2013

Conditions

Keywords

Nerve blockSciatic nerveUltrasonographyOrthopedicsHallux ValgusAmputationArthrodesisArthroscopyFracture fixationOsteotomyTendon transferTenodesisTenotomyOrthopedic procedure

Outcome Measures

Primary Outcomes (1)

  • Latency period of sciatic nerve block.

    Once the nerve blockade is done, a sensory evaluation will be performed in the surgical area every five minutes to determine the onset of the sensory nerve blockade in minutes.

    5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes and 30 minutes after nerve block.

Secondary Outcomes (17)

  • Success of sciatic nerve block

    Every 5 minutes until 30 minutes until the end of the procedure for the nerve block; an additional measure will be performed at the end of of the surgery.

  • Patient satisfaction

    Postoperative 24 hours

  • Sensory block

    5, 10, 15, 20, 25 and 30 minutes after the block is finished

  • Motor block

    5, 10, 15, 20, 25 and 30 minutes of completion after the block is finished

  • First analgesic

    5 minutes, 30 minutes, 24 hours postoperative

  • +12 more secondary outcomes

Study Arms (2)

Sciatic nerve blockade at bifurcation

EXPERIMENTAL

Ultrasound-guided block at the bifurcation of the sciatic nerve

Procedure: Sciatic nerve anesthesia blockade at bifurcation.Drug: Levobupivacaine 0.5%: 20 mlDevice: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WADevice: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)Drug: supplemental oxygenDrug: MidazolamDrug: Intravenous analgesicsProcedure: Saphenous nerve block

Sciatic block 2 cm beyond bifurcation

EXPERIMENTAL

Ultrasound-guided block of the sciatic nerve 2 cm beyond of the bifurcation

Procedure: Sciatic nerve blockade 2 cm beyond the bifurcationDrug: Levobupivacaine 0.5%: 20 mlDevice: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WADevice: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany)Drug: supplemental oxygenDrug: MidazolamDrug: Intravenous analgesicsProcedure: Saphenous nerve block

Interventions

A proximal and distal initial scan and define the site to block the bifurcation. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% and a total volume of 20 mL.

Also known as: Sciatic Nerve Block
Sciatic nerve blockade at bifurcation

A proximal and distal initial scan and define the sites to block: tibial and peroneal nerves separate distal 2 cm from the bifurcation site. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% 10 mL tibial nerve and 10 mL to the peroneal nerve.

Also known as: Sciatic nerve block
Sciatic block 2 cm beyond bifurcation

Levobupivacaine is a local anesthetic that is commonly use for anesthesia nerve blockade.

Also known as: Local Anesthetic
Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

An ultrasound machine is a device that is widely used for the correct placement of the local anesthetic for anesthesia nerve blockade.

Also known as: Ultrasound
Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

This is a specific kind of needle that is widely used for anesthesia nerve blockade.

Also known as: Nerve blockade needle short bevel.
Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

supplemental oxygen during the block and/or during surgery

Also known as: oxygen
Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

Intravenous midazolam for sedation during the block and/or during surgery

Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

Intraoperative administration intravenous of dipyrone 30-50 mg/Kg and or intravenous ketoprofen 100 mg or diclofenac 75 mg or ketorolac 30 mg

Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

Depending on sensitive territory committed by the type of surgery suprapatellar saphenous nerve block guided by ultrasound with 100 mm Stimuplex needle and injection of levobupivacaine 0.5% (total volume: 5 ml).

Sciatic block 2 cm beyond bifurcationSciatic nerve blockade at bifurcation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for ankle or foot surgery at Hospital Pablo Tobón Uribe and Clínica CES.
  • Physical status classification of the American Society of Anesthesiologists (ASA) 1-3.
  • Age: 18-70 years.
  • Weight: 40-100 kg
  • Taller than 140 cm.

You may not qualify if:

  • No patient acceptance.
  • Contraindications for nerve block (coagulopathy, local anesthetics allergy, sepsis, infection at the site of puncture).
  • Neuropathy or myopathy affecting the lower limb.
  • Psychiatric or neurological diseases that alter the evaluation of patient.
  • Arrhythmias.
  • Heart failure.
  • Diabetes Mellitus.
  • Pregnancy.
  • Language barriers.
  • Anticoagulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital Pablo Tobón Uribe

Medellín, Antioquia, 050034, Colombia

Location

Clínica CES

Medellín, Antioquia, Colombia

Location

MeSH Terms

Conditions

Hallux ValgusAnkylosis

Interventions

LevobupivacaineAnesthetics, LocalUltrasonographyOxygenMidazolam

Condition Hierarchy (Ancestors)

Foot DeformitiesMusculoskeletal DiseasesJoint Diseases

Intervention Hierarchy (Ancestors)

BupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisChalcogensElementsInorganic ChemicalsGasesBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Marta I Berrio, MD

    CES University, Medellín, Antioquia, Colombia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marta I Berrio, MD

CONTACT

Juan-Felipe Vargas, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

November 10, 2012

First Posted

November 28, 2012

Study Start

April 1, 2013

Primary Completion

August 1, 2013

Study Completion

September 1, 2013

Last Updated

April 19, 2013

Record last verified: 2013-04

Locations